# Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder
Canonical URL: https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-announces-last-patient-dosed-in-pharmacokinetics-study-of-ad04-for-the-treatment-of-alcohol-use-disorder
Ticker: ADIL
Company: Adial Pharmaceuticals
Source: Adial Pharmaceuticals
Published: 2024-08-07 09:00 EST
Original Source URL: https://www.pressviewer.com
## Summary

<div class="b2iNewsItemBodyDiv"><link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="center"><em>Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04</em></p> <p align="center"><em>Topline results expected during the fou

## Article Body
Patient dosing has concluded for the second and last cohort of the pharmacokinetics study of AD04

Topline results expected during the fourth quarter

GLEN ALLEN, Va., Aug.  07, 2024  (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the...
## Recent Company News
- 2025-06-11 08:00 EST — [Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-advances-toward-phase-3-development-for-ad04) — Source: Adial Pharmaceuticals
- 2025-05-15 08:30 EST — [Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-reports-first-quarter-2025-financial-results-and-provides-business-update) — Source: Adial Pharmaceuticals
- 2025-05-13 08:30 EST — [Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-receives-milestone-payment-from-adovate-following-initiation-of-phase-1-study) — Source: Adial Pharmaceuticals
- 2025-05-08 08:30 EST — [Adial Pharmaceuticals Granted End of Phase 2 Meeting from the U.S. Food and Drug Administration](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-granted-end-of-phase-2-meeting-from-the-u-s-food-and-drug-administration) — Source: Adial Pharmaceuticals
- 2025-05-02 11:48 EST — [Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds](https://biopharmsignal.com/news/ADIL/adial-pharmaceuticals-announces-a-warrant-inducement-transaction-for-2-75-million-in-gross-proceeds) — Source: Adial Pharmaceuticals
## Related News
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
- 2026-07-29 12:25 EST — ICCM — [IceCure: SIO Petitions NCCN to Include Cryoablation in Breast Cancer Treatment Guidelines, Citing IceCure's FDA Clearance  of ProSense®](https://biopharmsignal.com/news/ICCM/icecure-sio-petitions-nccn-to-include-cryoablation-in-breast-cancer-treatment-gu-bec46cd3)